ASSOCIATION BETWEEN ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY, BONE MASS, AND OSTEOPOROSIS RISK FACTORS

QR Code

ASSOCIATION BETWEEN ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY, BONE MASS, AND OSTEOPOROSIS RISK FACTORS

Aim. To evaluate the association between β-adrenoblocker (β-AB), angiotensin-converting enzyme inhibitor (ACEI), and statin therapy, bone mineral density (BMD), and osteoporosis risk factors (RFs).Material and methods. This retrospective study (n=1163) included 42 men and 1121 women aged >40...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. E. Sobchenko, I. A. Skripnikova, V. E. Novikov, T. V. Popkova, I. S. Dydykina, A. V. Smirnov, V. A. Vygodin, E. L. Nasonov, S. A. Boytsov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2013-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	β-adrenoblockers angiotensin-converting enzyme inhibitors statins bone mineral density osteoporosis osteoporotic fractures
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/235
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
by: N. V. Toroptsova, et al.
Published: (2014-06-01)

Prevalence rate of osteoporosis complications in Ulan-Ude residents
by: T. I. Batudaeva, et al.
Published: (2015-04-01)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015-12-01)

Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength
by: I. A. Skripnikova, et al.
Published: (2019-03-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

The experience of the parenteral form of ibandrinic acid administration in different clinical situations of treatment of postmenopausal osteoporosis
by: L. A. Marchenkova, et al.
Published: (2021-06-01)

Secondary prevention of osteoporosis and osteoporotic fractures in real clinical practice and possibilities of its improvement with strontium ranelate
by: Nataliya Vladimirovna Toroptsova
Published: (2012-03-01)

SYSTEMIC OSTEOPOROSIS AND PSORIATIC ARTHRITIS: CURRENT UNDERSTANDING OF THE PROBLEM
by: O. V. Dobrovolskaya, et al.
Published: (2017-10-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
by: Natalia Vladimirovna Toroptsova, et al.
Published: (2013-12-01)

Acute Osteoporotic Vertebral Fracture. Part 1. Definitions, Clinical Presentation, Pain Assessment, Diagnostic Imaging, Introduction to Differential Diagnosis
by: V. V. Lyalina, et al.
Published: (2022-08-01)

Acute Osteoporotic Vertebral Fracture. Part 2. Differential Diagnostics According to the Data of Imaging Methods. Conservative and Surgical Treatment
by: V. V. Lyalina, et al.
Published: (2022-12-01)

GLUCOCORTICOID-INDUCED OSTEOPOROSIS: DIAGNOSIS, PREVENTION, AND TREATMENT
by: N. V. Toroptsova
Published: (2014-09-01)

Artificial intelligence for predicting the risk of bone fragility fractures in osteoporosis
by: Fabio Massimo Ulivieri, et al.
Published: (2025-06-01)

Classification of Osteoporotic Vertebral Compression Fractures – Current Updates and How to Manage Them
by: Aditya Kasture, et al.
Published: (2025-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01)

The risk of fractures and the need for anti-osteoporotic treatment in patients with systemic sclerosis
by: A. О. Efremova, et al.
Published: (2021-02-01)

Associations of absolute risk of osteoporotic fractures (FRAX®) and total cardiovascular risk (SCORE) in urban population of the Russian Federation
by: M. A. Myagkova, et al.
Published: (2019-11-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA)
by: M. M. Loukianov, et al.
Published: (2017-05-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

Glucocorticoid induced osteoporosis in neurological patients: prevention and treatment
by: K. V. Antonova, et al.
Published: (2017-09-01)

SPECIFIC PROPERTIES OF THE DRUG THERAPY FOR STABLE ANGINA IN MEN
by: R. G. Oganov, et al.
Published: (2014-04-01)

TREATMENT OF OSTEOPOROSIS IN REAL CLINICAL PRACTICE: FREQUENCY OF PRESCRIPTIONS AND THERAPY ADHERENCE WITHIN THE FIRST YEAR AFTER OSTEOPOROTIC FRACTURE
by: O. V. Dobrovolskaya, et al.
Published: (2011-06-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

Experience with denosumab therapy for osteoporosis in rheumatoid arthritis patients receiving glucocorticoids
by: I. S. Dydykina, et al.
Published: (2018-06-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

MODERN POTENTIAL OF MYOCARDIAL INFARCTION TREATMENT IN THE POLYCLINIC SETTINGS (LECTURE)
by: Yu. I. Nesterov
Published: (2013-06-01)

AN EPIDEMIOLOGICAL SURVEY OF OSTEOPOROTIC FRACTURES IN OLDER RESIDENTS FROM THE MIDDLE URALS
by: E. N. Gladkova, et al.
Published: (2014-12-01)

A Narrative Review for Mechanisms and Management of Secondary Vertebral Collapse Following Minimally Invasive Bone Cement Augmentation Procedures for Osteoporotic Vertebral Compression Fractures
by: Bing-Yi Yang, et al.
Published: (2025-12-01)

COMPARISON OF EFFECTIVENESS OF COMBINATION ANTIHYPERTENSION THERAPY IN WOMEN WITH ABDOMINAL OR GLUTEO-FEMORAL OBESITY
by: V. V. Skibitsky, et al.
Published: (2016-10-01)

RISK FACTORS FOR OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS (PRELIMINARY RESULTS ACCORDING TO THE MATERIALS OF THE MULTICENTER PROGRAM «OSTEOPOROSIS IN RHEUMATOID ARTHRITIS: DIAGNOSIS, RISK FACTORS, FRACTURES, TREATMENT»)
by: E. A. Taskina, et al.
Published: (2014-09-01)

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy
by: V. V. Neroev, et al.
Published: (2020-12-01)

The Effect of ACE Inhibitors/ARBs Withdrawal on the Risk of Postoperative Complications in Abdominal Surgery
by: N. V. Trembach, et al.
Published: (2023-10-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

Combined lipid-lowering and antihypertensive therapy effects on hemostasis in metabolic sydrome patients
by: L. A. Ratnikova, et al.
Published: (2006-04-01)